Renaissance Technologies’s Ventyx Biosciences VTYX Stock Holding History

Renaissance Technologies’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-538,071	Closed	-$4.86M	–	3737
2025 Q4	$4.86M	Buy	538,071 +303,071	+129%	+$2.26M	0.01%	1325
2025 Q3	$731K	Buy	235,000 +163,700	+230%	+$434K	﹤0.01%	2640
2025 Q2	$153K	Sell	71,300 -945,089	-93%	-$1.53M	﹤0.01%	3224
2025 Q1	$1.17M	Buy	1,016,389 +391,889	+63%	+$673K	﹤0.01%	2319
2024 Q4	$1.37M	Buy	624,500 +310,800	+99%	+$704K	﹤0.01%	2304
2024 Q3	$684K	Buy	+313,700	New	+$721K	﹤0.01%	2643
2024 Q1	–	Sell	-429,200	Closed	-$1.06M	–	4116
2023 Q4	$1.06M	Buy	+429,200	New	+$4.08M	﹤0.01%	2364
2023 Q2	–	Sell	-29,600	Closed	-$992K	–	4297
2023 Q1	$992K	Buy	29,600 +22,800	+335%	+$887K	﹤0.01%	2482
2022 Q4	$223K	Buy	6,800 +1,000	+17%	+$29.6K	﹤0.01%	3369
2022 Q3	$202K	Buy	+5,800	New	+$128K	﹤0.01%	3382

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Renaissance Technologies's VTYX Position: Q1 2026 in Review

Renaissance Technologies sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 538,071 shares — an estimated $4.86M sold.

Renaissance Technologies first reported a position in VTYX in Q3 2022 and held it in 10 quarters. The position peaked at $4.86M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Renaissance Technologies reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Renaissance Technologies sold 538,071 Ventyx Biosciences shares in Q1 2026, an estimated $4.86M.
Renaissance Technologies first reported a position in Ventyx Biosciences in Q3 2022 and held it in 10 quarters.
Renaissance Technologies's Ventyx Biosciences position peaked at $4.86M in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.